ZA200208603B - The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals. - Google Patents

The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals.

Info

Publication number
ZA200208603B
ZA200208603B ZA200208603A ZA200208603A ZA200208603B ZA 200208603 B ZA200208603 B ZA 200208603B ZA 200208603 A ZA200208603 A ZA 200208603A ZA 200208603 A ZA200208603 A ZA 200208603A ZA 200208603 B ZA200208603 B ZA 200208603B
Authority
ZA
South Africa
Prior art keywords
mammals
bacterial
treating
preventing
protozoal infection
Prior art date
Application number
ZA200208603A
Other languages
English (en)
Inventor
Boettner Wayne Alan
Peter Connor Canning
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA200208603B publication Critical patent/ZA200208603B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200208603A 2000-04-27 2002-10-24 The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals. ZA200208603B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19996100P 2000-04-27 2000-04-27

Publications (1)

Publication Number Publication Date
ZA200208603B true ZA200208603B (en) 2003-10-24

Family

ID=22739732

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200208603A ZA200208603B (en) 2000-04-27 2002-10-24 The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals.

Country Status (30)

Country Link
US (2) US20020019353A1 (bg)
EP (1) EP1276747A1 (bg)
JP (1) JP2004516233A (bg)
KR (1) KR20030031479A (bg)
CN (1) CN1227258C (bg)
AP (1) AP2002002652A0 (bg)
AR (1) AR028041A1 (bg)
AU (1) AU4269301A (bg)
BG (1) BG107168A (bg)
BR (1) BR0110382A (bg)
CA (1) CA2407448A1 (bg)
CZ (1) CZ20023409A3 (bg)
EA (1) EA200200995A1 (bg)
GT (1) GT200100063A (bg)
HU (1) HUP0300585A3 (bg)
IL (1) IL152421A0 (bg)
IS (1) IS6559A (bg)
MA (1) MA26896A1 (bg)
MX (1) MXPA02010586A (bg)
NO (1) NO20025134L (bg)
OA (1) OA12257A (bg)
PA (1) PA8515601A1 (bg)
PE (1) PE20011188A1 (bg)
PL (1) PL359861A1 (bg)
SK (1) SK14882002A3 (bg)
TN (1) TNSN01063A1 (bg)
UY (1) UY26678A1 (bg)
WO (1) WO2001081358A1 (bg)
YU (1) YU78702A (bg)
ZA (1) ZA200208603B (bg)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
WO2009006466A1 (en) * 2007-07-02 2009-01-08 Novus International Inc. Feeding regime for prevention of porcine enteropathic conditions
US8314071B2 (en) 2007-12-21 2012-11-20 Massachusetts Institute Of Technology Bioactive molecules from co-cultivation of microbes
US10568923B2 (en) * 2012-06-27 2020-02-25 Kemin Industries, Inc. Plant parts and extracts having anticoccidial activity
CN104936583A (zh) * 2012-06-27 2015-09-23 凯敏工业公司 具有抗球虫活性的植物部分及提取物
BR112018076609B1 (pt) 2016-12-15 2023-02-14 Société des Produits Nestlé S.A. Composição alimentícia para animais de estimação, seus usos, e métodos não terapêutico para modular a quantidade e para medição de uma alteração na quantidade de pelo menos uma dentre bifidobacterium, lactobacillus ou clostridium perfringens
CN106905395A (zh) * 2017-02-21 2017-06-30 西南大学 丁二酸替米考星复盐的制备方法
CN106749458A (zh) * 2017-02-21 2017-05-31 西南大学 苹果酸替米考星复盐的制备方法
CN106905396A (zh) * 2017-02-21 2017-06-30 西南大学 富马酸替米考星复盐的制备方法
US11059845B2 (en) * 2017-02-22 2021-07-13 ISR Immune System Regulation Holding AB (publ) Immune stimulating macrolides
CA3120148A1 (en) * 2018-11-19 2020-05-28 Zikani Therapeutics, Inc. C10-alkylene substituted 13-membered macrolides and uses thereof
CN109535211B (zh) * 2018-12-19 2020-05-08 江苏威凌生化科技有限公司 一种合成纯化泰拉霉素杂质c的方法
CN118139870A (zh) * 2021-09-07 2024-06-04 硕腾服务有限责任公司 免疫调节氮环内酯

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
JP2004516233A (ja) 2004-06-03
PL359861A1 (en) 2004-09-06
CZ20023409A3 (cs) 2004-01-14
PE20011188A1 (es) 2001-11-24
BR0110382A (pt) 2003-06-24
UY26678A1 (es) 2001-12-28
NO20025134D0 (no) 2002-10-25
YU78702A (sh) 2005-11-28
TNSN01063A1 (fr) 2005-11-10
CA2407448A1 (en) 2001-11-01
NO20025134L (no) 2002-12-19
MXPA02010586A (es) 2003-03-10
US20040235759A1 (en) 2004-11-25
CN1227258C (zh) 2005-11-16
HUP0300585A3 (en) 2003-09-29
GT200100063A (es) 2002-02-18
IL152421A0 (en) 2003-05-29
PA8515601A1 (es) 2002-07-30
OA12257A (en) 2003-11-06
WO2001081358A1 (en) 2001-11-01
SK14882002A3 (en) 2004-11-03
MA26896A1 (fr) 2004-12-20
US20020019353A1 (en) 2002-02-14
AP2002002652A0 (en) 2002-12-31
AU4269301A (en) 2001-11-07
BG107168A (bg) 2003-07-31
CN1429232A (zh) 2003-07-09
EP1276747A1 (en) 2003-01-22
EA200200995A1 (ru) 2003-04-24
AR028041A1 (es) 2003-04-23
HUP0300585A2 (hu) 2003-06-28
IS6559A (is) 2002-09-20
KR20030031479A (ko) 2003-04-21

Similar Documents

Publication Publication Date Title
ZA200208603B (en) The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals.
TWI318880B (en) Azalide antibiotic compositions
MXPA03003168A (es) Composicion antibiotica topica para el tratamiento de infeccion de los ojos.
MXPA03004504A (es) Sistemas de tratamiento oral.
ZA200108912B (en) Attenuated microorganisms for the treatment of infection.
IL192666A0 (en) Spontaneously dispersible n-benzoyl staurosporine compositions
MX264033B (es) Tratamieno de enzimas para infeccion.
PL365453A1 (en) Compounds and methods for the treatment and prevention of bacterial infection
GB0005985D0 (en) Level-shifting pass gate
ZA200103289B (en) Novel macrolide antibiotics.
MXPA00007394A (es) Compuestos, composiciones y metodos para tratar o evitar infeccion de neumovirus y enfermedades asociadas.
EP1135137A4 (en) COPOLYMER COMPOSITIONS FOR TREATING VIRAL INFECTIONS
AU1646701A (en) Composition for treating respiratory tract infections
AU7272900A (en) Phage resistant bacteria
ZA991410B (en) Compounds and methods for the treatment of bacterial dysentry using antibiotics and toxin binding oligosaccharide compositions.
AU1772299A (en) Well treatment with microorganisms
EP1233967A4 (en) PYRIDINONES FOR THE TREATMENT AND PREVENTION OF BACTERIAL INFECTIONS
AU2001258675A1 (en) Treating infections
EP1343870A4 (en) BACTERIAL EXPRESSION SYSTEMS
GB0016842D0 (en) Bacterial polysaccharide
AU3698199A (en) Radioimmuno-pharmacon for treating the hiv-1 infection
IL152984A0 (en) Hygromycin a derivatives for the treatment of bacterial and protozoal infections
AU2002221748A1 (en) Stain treatment composition
EP1439186A3 (en) Intermediates for novel antibacterial and prokinetic macrolides
AU2003204710A1 (en) Attenuated microorganisms for the treatment of infection